The presence of both cellular and stromal FN1 and its interaction with integrins is necessary for pancreatic cancer progression, and inhibition of FN1 signaling was previously shown be an effective treatment strategy in vivo [68]. The gene discussed is FN1; the disease is familial pancreatic carcinoma.